Kahnert, K.* ; Jörres, R.A.* ; Kauczor, H.U.* ; Biederer, J.* ; Jobst, B.* ; Alter, P.* ; Biertz, F.* ; Mertsch, P.* ; Lucke, T.* ; Lutter, J. ; Trudzinski, F.C.* ; Behr, J.* ; Bals, R.* ; Watz, H.* ; Vogelmeier, C.F.* ; Welte, T.*
     
 
    
        
Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET.
    
    
        
    
    
        
        Respir. Med. 172:106117 (2020)
    
    
    
		
		
			
				Bronchiectasis (BE) might be frequently present in COPD but masked by COPD symptoms. We studied the relationship of clinical signs of bronchiectasis to the presence and extent of its radiological signs in patients of different COPD severity.Visit 4 data (GOLD grades 1-4) of the COSYCONET cohort was used. Chest CT scans were evaluated for bronchiectasis in 6 lobes using a 3-point scale (0: absence, 1: <= 50%, 2: >50% BE-involvement for each lobe).1176 patients were included (61%male, age 67.3y), among them 38 (3.2%) with reported physicians' diagnosis of bronchiectasis and 76 (6.5%) with alpha1-antitrypsin deficiency (AA1D). CT scans were obtained in 429 patients. Within this group, any signs of bronchiectasis were found in 46.6% of patients, whereby <= 50% BE occurred in 18.6% in <= 2 lobes, in 10.0% in 3-4 lobes, in 15.9% in 5-6 lobes; >50% bronchiectasis in at least 1 lobe was observed in 2.1%. Scores >= 4 correlated with an elevated ratio FRC/RV. The clinical diagnosis of bronchiectasis correlated with phlegm and cough and with radiological scores of at least 3, optimally >= 5.In COPD patients, clinical diagnosis and radiological signs of BE showed only weak correlations. Correlations became significant with increasing BE-severity implying radiological alterations in several lobes. This indicates the importance of reporting both presence and extent of bronchiectasis on CT. Further research is warranted to refine the criteria for CT scoring of bronchiectasis and to determine the relevance of radiologically but not clinically detectible bronchiectasis and their possible implications for therapy in COPD patients.
			
			
				
			
		 
		
			
				
					
					Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Scopus
Cited By
					
					Altmetric
					
				 
				
			 
		 
		
     
    
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
    
        Typ der Hochschulschrift
        
    
 
    
        Herausgeber
        
    
    
        Schlagwörter
        Copd ; Bronchiectasis ; Ct Scan ; Lung Function ; Symptoms; Obstructive Pulmonary-disease; Ct Findings; Diagnosis; Adults
    
 
    
        Keywords plus
        
    
 
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2020
    
 
    
        Prepublished im Jahr 
        
    
 
    
        HGF-Berichtsjahr
        2020
    
 
    
    
        ISSN (print) / ISBN
        0954-6111
    
 
    
        e-ISSN
        1532-3064
    
 
    
        ISBN
        
    
 
    
        Bandtitel
        
    
 
    
        Konferenztitel
        
    
 
	
        Konferzenzdatum
        
    
     
	
        Konferenzort
        
    
 
	
        Konferenzband
        
    
 
     
		
    
        Quellenangaben
        
	    Band: 172,  
	    Heft: ,  
	    Seiten: ,  
	    Artikelnummer: 106117 
	    Supplement: ,  
	
    
 
  
        
            Reihe
            
        
 
        
            Verlag
            Elsevier
        
 
        
            Verlagsort
            32 Jamestown Rd, London Nw1 7by, England
        
 
	
        
            Tag d. mündl. Prüfung
            0000-00-00
        
 
        
            Betreuer
            
        
 
        
            Gutachter
            
        
 
        
            Prüfer
            
        
 
        
            Topic
            
        
 
	
        
            Hochschule
            
        
 
        
            Hochschulort
            
        
 
        
            Fakultät
            
        
 
    
        
            Veröffentlichungsdatum
            0000-00-00
        
 
         
        
            Anmeldedatum
            0000-00-00
        
 
        
            Anmelder/Inhaber
            
        
 
        
            weitere Inhaber
            
        
 
        
            Anmeldeland
            
        
 
        
            Priorität
            
        
 
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        80000 - German Center for Lung Research
30202 - Environmental Health
    
 
    
        Forschungsfeld(er)
        Genetics and Epidemiology
Lung Research
    
 
    
        PSP-Element(e)
        G-501800-533
G-501600-001
    
 
    
        Förderungen
        Novartis Deutschland GmbH
Grifols Deutschland GmbH
GlaxoSmithKline GmbHCo. KG
Boehringer Ingelheim Pharma GmbH Co. KG
AstraZeneca GmbH
BMBF
German Centre for Lung Research (DZL)
    
 
    
        Copyright
        
    
 	
    
    
    
    
        Erfassungsdatum
        2020-10-26